Clinical response to adalimumab: relationship to anti‐adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

BACKGROUND: A substantial proportion of patients with rheumatoid arthritis (RA) do not respond, or lose initial response, to adalimumab treatment. One explanation for non‐response is that patients develop anti‐adalimumab antibodies. OBJECTIVES: To evaluate the incidence of formation of antibody agai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bartelds, Geertje M, Wijbrandts, Carla A, Nurmohamed, Michael T, Stapel, Steven, Lems, Willem F, Aarden, Lucien, Dijkmans, Ben A C, Tak, Paul Peter, Wolbink, Gerrit Jan
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2007
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955110/
https://ncbi.nlm.nih.gov/pubmed/17301106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.065615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars